Insights

Memo/April 2026, 9 min

Why the verified-HCP market is fragmenting again.

The verified-HCP media market is entering another fragmentation cycle. The issue is not simply more vendors, it is more incompatible claims about identity, audience quality, and measurable reach.

The market signal

HCP media teams are seeing a familiar pattern: more verified audiences, more endemic networks, more point solutions, and more claims that sound comparable but are not operationally equivalent.

The practical risk is not choice. The risk is that a launch plan can look diversified on paper while relying on the same underlying identity sources, inventory paths, or measurement assumptions.

What brand teams should test

Before renewing a publisher or platform contract, teams should ask how verification is maintained, how NPI-level duplication is handled, how audience exclusions work, and how reporting can be reconciled against other partners.

The strongest partner is rarely the one with the broadest claim. It is the one whose claim can survive an operational audit after the launch pressure is on.

The governance implication

A vendor-neutral review creates a record of why each partner is in the plan, what role each one plays, and what signal would cause spend to move. That record becomes especially valuable when procurement, legal, medical, and commercial leadership all need the same answer.

Apply this to your launch

Turn the note into an operating standard.

Cadence helps pharma and biotech teams translate these governance questions into a practical launch plan, vendor diligence process, and measurement record.

Schedule Advisory Call